Recent Drugs Approved for Treatment of Renal Cell Carcinoma (RCC)

In the last four years, six new drugs have been approved by the United States Food and Drug Administration for the treatment of kidney cancer. They are:

sorafenib, bevacizumab, sunitinib, temsirolimus, everolimus, and pazopanib

Written by

No Comments Yet.

Leave a Reply